GlobalData on MSN
Neurovalens receives EU MDR compliance for sleep insomnia device
Achieving MDR compliance shows Modius Sleep meets safety, clinical, and quality standards required for entry into the EU ...
Neurovalens announced today that it received approval for its first neuromodulation product in Europe and the UK.
Modius Sleep is currently available via prescription in the US for $2,265 (£1,690) ...
Belfast News Letter on MSN
'Another significant landmark': Northern Ireland medical tech manufacturer granted EU and UK approval for innovative insomnia device
Modius Sleep, a non-invasive, prescription-only neurostimulation device, offers a new drug-free approach to treating insomnia ...
Belfast-based neurotechnology company Neurovalens has received approval for its prescribed insomnia treatment from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results